Impact of interferon-induced transmembrane protein 3 gene rs12252 polymorphism on COVID-19 mortality

Iraj Ahmadi1, Alireza Afifipour1, Fatemeh Sakhaee2

  • 1Department of Physiology, School of Medicine, Ilam University of Medical Science, Ilam, Iran.

Cytokine
|July 6, 2022
PubMed
Abstract

Insights

The IFITM3 rs12252 CC genotype was more frequent in patients who died from COVID-19. This genetic factor, along with clinical markers, may be linked to increased coronavirus disease 2019 mortality.

Area of Science:

  • Immunogenetics
  • Virology
  • Genetics

Background:

  • Interferon-induced transmembrane protein 3 (IFITM3) is crucial for immune responses, inhibiting viral entry.
  • IFITM3's role in preventing host-viral membrane fusion is key to its function.
  • Genetic variations in IFITM3 may influence susceptibility and severity of viral infections.

Purpose of the Study:

  • To investigate the association between IFITM3 rs12252 polymorphism and COVID-19 mortality.
  • To determine if specific IFITM3 genotypes correlate with increased risk of death from SARS-CoV-2 infection.

Main Methods:

  • Genotyping of IFITM3 rs12252 polymorphism using ARMS-PCR.
  • Analysis included 548 deceased and 630 recovered COVID-19 patients.
  • Multivariate logistic regression was employed to identify risk factors.

Main Results:

  • The minor allele frequency (C) of IFITM3 rs12252 was higher in non-survivors.
  • IFITM3 rs12252 CC genotypes were significantly associated with COVID-19 mortality.
  • Lower lipid profiles, vitamin D, uric acid, and higher ESR, liver enzymes, and creatinine were also linked to mortality.

Conclusions:

  • Findings suggest a potential link between IFITM3 rs12252 CC genotype and COVID-19 mortality.
  • Clinical parameters also showed significant associations with fatal outcomes.
  • Further global research is needed to confirm the role of host genetics in COVID-19 mortality.